Phase III Multicenter Randomized Trial of the Dartmouth Regimen Versus Dacarbazine in Patients With Metastatic Melanoma
- 1 September 1999
- journal article
- clinical trial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 17 (9), 2745
- https://doi.org/10.1200/jco.1999.17.9.2745
Abstract
PURPOSE: Several single-institution phase II trials have reported that the Dartmouth regimen (dacarbazine, cisplatin, carmustine, and tamoxifen) can induce major tumor responses in 40% to 50% of st...Keywords
This publication has 27 references indexed in Scilit:
- Prognostic factors in patients with metastatic malignant melanoma: A multivariate analysisCancer, 1993
- A phase II trial of high-dose cisplatin and dacarbazine. Lack of efficacy of high-dose, cisplatin-based therapy for metastatic melanomaCancer, 1991
- High-Dose Cisplatin and Dacarbazine in the treatment of Metastatic MelanomaJNCI Journal of the National Cancer Institute, 1990
- A prospective evaluation of a triple-drug regimen containing cisplatin, vinblastine, and dacarbazine (CVD) for metastatic melanomaCancer, 1989
- Bleomycin, vincristine, lomustine, and DTIC chemotherapy for metastatic melanomaCancer, 1988
- Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic CancerNew England Journal of Medicine, 1985
- Dimethyl triazeno imidazole carboxamide and combination therapy for melanoma IV. Late results after complete response to chemotherapy (central oncology group protocols 7130, 7131, and 7131A)Cancer, 1984
- Vinblastine, bleomycin, and cis-platinum for the treatment of metastatic malignant melanoma. National Cancer Institute of Canada Melanoma Group.Journal of Clinical Oncology, 1984
- Vinblastine, infusion, bleomycin, and cis-dichlorodiammine-platinum chemotherapy in metastatic melanomaCancer, 1981
- DTIC, CCNU, bleomycin and vincristine (BOLD) in metastatic melanomaCancer, 1980